Eden Abetu Mehari
(UOG, October, 2)
Abstract
Introduction: The toxicity of the therapeutic regimen, treatment failure, and resistance to
existing HIV medications becomes a challenge in resource-limited settings. To tackle this
dolutegravir-based regimen has ...